Leflunomide therapy for refractory cytomegalovirus infections in hematopoietic stem cell transplant recipients. [electronic resource]
Producer: 20191125Description: 1731-1737 p. digitalISSN:- 1477-092X
- Adult
- Aged
- Cytomegalovirus Infections -- drug therapy
- DNA, Viral
- DNA-Directed DNA Polymerase -- genetics
- Female
- Genotype
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Leflunomide -- administration & dosage
- Male
- Middle Aged
- Mutation
- Retrospective Studies
- Viral Proteins -- genetics
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.